Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Anne Tybjærg-Hansen
Title
Prof
Bio
Professor, MD, DMSc,
Rigshospitalet and University of Copenhagen, Denmark
Chief Physician at the Department of Clinical Biochemistry at Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark (1999). Clinical Professor of Clinical Biochemistry with Focus on Translational Molecular Cardiology at the Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark (2009).
Graduated as medical doctor from the University of Copenhagen in 1981. Board certified as a specialist in Clinical Biochemistry 1996. Scientific education included 1 year at the University of Copenhagen and the Lipid Clinic at Righospitalet, Copenhagen University Hospital. Three years at Hagedorn Research Laboratory, Gentofte, Denmark, and 3 years (87-89) at British Heart Foundation’s Molecular Biology Research Group, London, UK.
AT-H’s research has focused on the genetics and genomics of cardiovascular disease and related diseases in large prospective studies of the general population (>150.000 participants). Recent focus areas include Mendelian randomization, polygenic risk scores for dyslipidemia and CAD, and amyloidosis and amyloidosis-related heart disease and other diseases.
AT-H is a current member of the steering committees of the Copenhagen City Heart Study and the Copenhagen General Population Study, and Executive Editor for European Heart Journal 2020 and ongoing.
Honors include: Honorary member, Czeck Atherosclerosis Society 2017. EAS’ Anitschkow Prize for 2018. JLR Distinguished Lecture, ISA Toronto 2018. Albert Latner Memorial Lecture, Univ. of Newcastle 2018. The KFJ Prize for 2018, University of Copenhagen, Denmark. National Lipid Association (NLA) USA, Honorary Lifetime Membership Award 2021.
Rigshospitalet and University of Copenhagen, Denmark
Chief Physician at the Department of Clinical Biochemistry at Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark (1999). Clinical Professor of Clinical Biochemistry with Focus on Translational Molecular Cardiology at the Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark (2009).
Graduated as medical doctor from the University of Copenhagen in 1981. Board certified as a specialist in Clinical Biochemistry 1996. Scientific education included 1 year at the University of Copenhagen and the Lipid Clinic at Righospitalet, Copenhagen University Hospital. Three years at Hagedorn Research Laboratory, Gentofte, Denmark, and 3 years (87-89) at British Heart Foundation’s Molecular Biology Research Group, London, UK.
AT-H’s research has focused on the genetics and genomics of cardiovascular disease and related diseases in large prospective studies of the general population (>150.000 participants). Recent focus areas include Mendelian randomization, polygenic risk scores for dyslipidemia and CAD, and amyloidosis and amyloidosis-related heart disease and other diseases.
AT-H is a current member of the steering committees of the Copenhagen City Heart Study and the Copenhagen General Population Study, and Executive Editor for European Heart Journal 2020 and ongoing.
Honors include: Honorary member, Czeck Atherosclerosis Society 2017. EAS’ Anitschkow Prize for 2018. JLR Distinguished Lecture, ISA Toronto 2018. Albert Latner Memorial Lecture, Univ. of Newcastle 2018. The KFJ Prize for 2018, University of Copenhagen, Denmark. National Lipid Association (NLA) USA, Honorary Lifetime Membership Award 2021.
